These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 35112032)
1. Treatment of recalcitrant Acanthamoeba Keratitis with Photoactivated Chromophore for Infectious Keratitis Corneal Collagen Cross-Linking (PACK-CXL). Watson SH; Shekhawat NS; Daoud YJ Am J Ophthalmol Case Rep; 2022 Mar; 25():101330. PubMed ID: 35112032 [TBL] [Abstract][Full Text] [Related]
2. High fluence PACK-CXL as adjuvant treatment for advanced Acanthamoeba keratitis. Nateghi Pettersson M; Lagali N; Mortensen J; Jofré V; Fagerholm P Am J Ophthalmol Case Rep; 2019 Sep; 15():100499. PubMed ID: 31312750 [TBL] [Abstract][Full Text] [Related]
3. Photoactivated chromophore for infectious keratitis - Corneal cross-linking (PACK-CXL): A systematic review and meta-analysis. Ting DSJ; Henein C; Said DG; Dua HS Ocul Surf; 2019 Oct; 17(4):624-634. PubMed ID: 31401338 [TBL] [Abstract][Full Text] [Related]
4. Photoactivated chromophore corneal cross-linking (PACK-CXL) for treatment of severe keratitis. Idrus EA; Utti EM; Mattila JS; Krootila K Acta Ophthalmol; 2019 Nov; 97(7):721-726. PubMed ID: 30593737 [TBL] [Abstract][Full Text] [Related]
5. Collagen cross-linking with photoactivated riboflavin (PACK-CXL) for the treatment of advanced infectious keratitis with corneal melting. Said DG; Elalfy MS; Gatzioufas Z; El-Zakzouk ES; Hassan MA; Saif MY; Zaki AA; Dua HS; Hafezi F Ophthalmology; 2014 Jul; 121(7):1377-82. PubMed ID: 24576886 [TBL] [Abstract][Full Text] [Related]
6. Comparison of corneal collagen cross-linking (PACK-CXL) and voriconazole treatments in experimental fungal keratitis. Özdemir HB; Kalkancı A; Bilgihan K; Göçün PU; Öğüt B; Karakurt F; Erdoğan M Acta Ophthalmol; 2019 Feb; 97(1):e91-e96. PubMed ID: 29862655 [TBL] [Abstract][Full Text] [Related]
7. The bactericidal effect of two photoactivated chromophore for keratitis-corneal crosslinking protocols (standard vs. accelerated) on bacterial isolates associated with infectious keratitis in companion animals. Suter A; Schmitt S; Hübschke E; Kowalska M; Hartnack S; Pot S BMC Vet Res; 2022 Aug; 18(1):317. PubMed ID: 35978428 [TBL] [Abstract][Full Text] [Related]
8. Photoactivated Chromophore for Keratitis-Corneal Collagen Cross-Linking (PACK-CXL) Improves Outcomes of Treatment-Resistant Infectious Keratitis. Gulias-Cañizo R; Benatti A; De Wit-Carter G; Hernández-Quintela E; Sánchez-Huerta V Clin Ophthalmol; 2020; 14():4451-4457. PubMed ID: 33376299 [TBL] [Abstract][Full Text] [Related]
9. Intraoperative Photoactivated Chromophore for Infectious Keratitis-Corneal Cross-Linking (PACK-CXL) During Penetrating Keratoplasty for the Management of Fungal Keratitis in an Immunocompromised Patient. Mikropoulos DG; Kymionis GD; Voulgari N; Kaisari E; Nikolakopoulos KA; Katsanos A; Konstas AG Ophthalmol Ther; 2019 Sep; 8(3):491-495. PubMed ID: 31278588 [TBL] [Abstract][Full Text] [Related]
10. Photoactivated Chromophore Corneal Collagen Cross-Linking for Infectious Keratitis (PACK-CXL)-A Comprehensive Review of Diagnostic and Prognostic Factors Involved in Therapeutic Indications and Contraindications. Barac IR; Artamonov AR; Baltă G; Dinu V; Mehedințu C; Bobircă A; Baltă F; Barac DA J Pers Med; 2022 Nov; 12(11):. PubMed ID: 36422083 [TBL] [Abstract][Full Text] [Related]
11. Corneal Collagen Cross-Linking With Photoactivated Chromophore for Infectious Keratitis After Penetrating Keratoplasty. Ozbek-Uzman S; Yalniz-Akkaya Z; Burcu A Cornea; 2020 Mar; 39(3):283-289. PubMed ID: 31764287 [TBL] [Abstract][Full Text] [Related]
12. PACK-CXL: Corneal Cross-linking for Treatment of Infectious Keratitis. Tabibian D; Richoz O; Hafezi F J Ophthalmic Vis Res; 2015; 10(1):77-80. PubMed ID: 26005557 [TBL] [Abstract][Full Text] [Related]
13. PACK-CXL: Corneal cross-linking in infectious keratitis. Tabibian D; Mazzotta C; Hafezi F Eye Vis (Lond); 2016; 3():11. PubMed ID: 27096139 [TBL] [Abstract][Full Text] [Related]
14. PACK-CXL vs. antimicrobial therapy for bacterial, fungal, and mixed infectious keratitis: a prospective randomized phase 3 trial. Hafezi F; Hosny M; Shetty R; Knyazer B; Chen S; Wang Q; Hashemi H; Torres-Netto EA; Eye Vis (Lond); 2022 Jan; 9(1):2. PubMed ID: 34996516 [TBL] [Abstract][Full Text] [Related]
15. Oral miltefosine for refractory Hirabayashi KE; Lin CC; Ta CN Am J Ophthalmol Case Rep; 2019 Dec; 16():100555. PubMed ID: 31650083 [TBL] [Abstract][Full Text] [Related]